US Bancorp’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-41,605
| Closed | -$749K | – | 3857 |
|
|
2020
Q2 | $749K | Sell |
41,605
-5,747
| -12% | -$103K | ﹤0.01% | 1091 |
|
|
2020
Q1 | $338K | Buy |
47,352
+844
| +2% | +$6.02K | ﹤0.01% | 1393 |
|
|
2019
Q4 | $1.11M | Sell |
46,508
-90
| -0.2% | -$2.15K | ﹤0.01% | 1012 |
|
|
2019
Q3 | $1.25M | Sell |
46,598
-1,920
| -4% | -$51.5K | ﹤0.01% | 935 |
|
|
2019
Q2 | $1.32M | Buy |
48,518
+199
| +0.4% | +$5.4K | ﹤0.01% | 960 |
|
|
2019
Q1 | $1.68M | Buy |
48,319
+4,185
| +9% | +$145K | ﹤0.01% | 842 |
|
|
2018
Q4 | $862K | Buy |
44,134
+2,530
| +6% | +$49.4K | ﹤0.01% | 1087 |
|
|
2018
Q3 | $1.11M | Sell |
41,604
-812
| -2% | -$21.6K | ﹤0.01% | 1048 |
|
|
2018
Q2 | $1.6M | Sell |
42,416
-2,203
| -5% | -$83.2K | ﹤0.01% | 894 |
|
|
2018
Q1 | $1.46M | Buy |
44,619
+829
| +2% | +$27.1K | ﹤0.01% | 917 |
|
|
2017
Q4 | $2.13M | Buy |
43,790
+941
| +2% | +$45.8K | 0.01% | 766 |
|
|
2017
Q3 | $2.32M | Buy |
42,849
+1,695
| +4% | +$91.6K | 0.01% | 737 |
|
|
2017
Q2 | $2.31M | Buy |
41,154
+48
| +0.1% | +$2.7K | 0.01% | 710 |
|
|
2017
Q1 | $1.61M | Buy |
41,106
+106
| +0.3% | +$4.15K | 0.01% | 862 |
|
|
2016
Q4 | $920K | Sell |
41,000
-500
| -1% | -$11.2K | ﹤0.01% | 1106 |
|
|
2016
Q3 | $943K | Buy |
41,500
+500
| +1% | +$11.4K | ﹤0.01% | 1055 |
|
|
2016
Q2 | $968K | Hold |
41,000
| – | – | ﹤0.01% | 1023 |
|
|
2016
Q1 | $836K | Hold |
41,000
| – | – | ﹤0.01% | 1073 |
|
|
2015
Q4 | $2.11M | Hold |
41,000
| – | – | 0.01% | 686 |
|
|
2015
Q3 | $1.75M | Buy |
41,000
+20,000
| +95% | +$852K | 0.01% | 741 |
|
|
2015
Q2 | $957K | Buy |
21,000
+11,000
| +110% | +$501K | ﹤0.01% | 1047 |
|
|
2015
Q1 | $380K | Buy |
+10,000
| New | +$380K | ﹤0.01% | 1487 |
|